1 Introduction Psoriasis is a chronic, systemic inflammatory disease affecting 2%–4% of the population [1]. It portends an increased risk of cardiovascular disease (CVD), which disproportionately affects younger patients with more severe psoriasis [2-5]. The prevalence of cardiovascular risk factors are also seen to be higher in patients with psoriasis, including hypertension, diabetes, dyslipidaemia, obesity and the metabolic syndrome [2-4].